BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22687409)

  • 1. Mutant soluble ectodomain of fibroblast growth factor receptor-2 IIIc attenuates bleomycin-induced pulmonary fibrosis in mice.
    Yu ZH; Wang DD; Zhou ZY; He SL; Chen AA; Wang J
    Biol Pharm Bull; 2012; 35(5):731-6. PubMed ID: 22687409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of α-SMA by the ectodomain of FGFR2c attenuates lung fibrosis.
    Ju W; Zhihong Y; Zhiyou Z; Qin H; Dingding W; Li S; Baowei Z; Xing W; Ying H; An H
    Mol Med; 2012 Sep; 18(1):992-1002. PubMed ID: 22451267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
    Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
    J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of a recombinant soluble ectodomain of mutant human fibroblast growth factor receptor-2 IIIc.
    Wang J; Liu XT; Huang H; Xiao G; Zhou ZY; Chen Y; Yu ZH; He SL; Chen AA; Wang DD; He Y; Zhang ZC; Hong A
    Mol Cancer Ther; 2011 Sep; 10(9):1656-66. PubMed ID: 21750221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
    Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
    Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L; Yang M; Tian X; Zhao P; Mei X; Bai Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1161-1166. PubMed ID: 36567559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
    Jin M; Wu Y; Wang L; Zang B; Tan L
    Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
    Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.
    Qu Y; Zhang G; Ji Y; Zhua H; Lv C; Jiang W
    Phytomedicine; 2016 Apr; 23(4):350-8. PubMed ID: 27002405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
    Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
    Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
    J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis.
    Arribillaga L; Dotor J; Basagoiti M; Riezu-Boj JI; Borrás-Cuesta F; Lasarte JJ; Sarobe P; Cornet ME; Feijoó E
    Cytokine; 2011 Mar; 53(3):327-33. PubMed ID: 21185199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
    Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
    Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.